Crossover Bioequivalence Study of Quetiapine Fumarate 25 mg Tablets Under Fasted Conditions

Clinical trial NCT01570907 · COMPLETED

Trial details

NCT number: NCT01570907
Sponsor: Roxane Laboratories
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Treatment for Bipolar I Disorder

Start date: 2007-06-01
Primary completion: 2007-07-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.